| Keywords: |
clinical feature; mortality; united states; human immunodeficiency virus infection; morbidity; prevalence; atrophy; exercise; history, 21st century; cost effectiveness analysis; history, 20th century; developed country; prophylaxis; diabetes mellitus; short survey; dyslipidemia; insulin resistance; human immunodeficiency virus; acquired immune deficiency syndrome; acquired immunodeficiency syndrome; antiretrovirus agent; cd4 lymphocyte count; highly active antiretroviral therapy; dietary intake; screening test; azithromycin; infection control; metabolic disorder; infection risk; tuberculosis; virus transmission; hiv infections; hiv; drug resistance, viral; epidemic; disease outbreaks; world health; confidentiality; south africa; body fat; glucose intolerance; lipodystrophy; communicable disease control
|
